Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression
Laura García-Durán, Antonio Flores‐Burgess, Noelia Cantero-García, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10848-10848
Open Access | Times Cited: 11

Showing 11 citing articles:

Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
Maja Jazvinšćak Jembrek, Nada Oršolić, Dalibor Karlović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6888-6888
Open Access | Times Cited: 20
Protective Role and Functional Engineering of Neuropeptides in Depression and Anxiety: An Overview
Nathalie Okdeh, Georges Mahfouz, Julien Harb, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 258-258
Open Access | Times Cited: 15
The role of dorsal raphe nucleus neuropeptides in reward and aversion
Kathryn Braden, Daniel C. Castro
Frontiers in Behavioral Neuroscience (2025) Vol. 19
Open Access
Galanin(1−15) and Naltrexone: A novel approach for alcohol use disorder in rats, involving the mesolimbic system
Marta Flores-Gómez, Noelia Cantero-García, Juan Pedro Pineda-Gómez, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 188, pp. 118170-118170
Closed Access
Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders
Miguel Pérez de la Mora, Dasiel O. Borroto‐Escuela, Minerva Crespo‐Ramírez, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1826-1826
Open Access | Times Cited: 12
Multi-level variations of lateral habenula in depression: A comprehensive review of current evidence
Guangming Zhang, Hong-Yun Wu, Wenqiang Cui, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 8
A new pharmacological strategy against treatment-resistant depression
Juan Pedro Pineda-Gómez, Carmelo Millón, Noelia Cantero-García, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111191-111191
Closed Access | Times Cited: 1
The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression
Noelia Cantero-García, Antonio Flores‐Burgess, David Ladrón de Guevara‐Miranda, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 412-412
Open Access | Times Cited: 3
Deciphering the role of siRNA in anxiety and depression
Rajeshwari Bale, Gaurav Doshi
European Journal of Pharmacology (2024) Vol. 981, pp. 176868-176868
Closed Access
Venlafaxine loaded novasomes for intranasal delivery: Mucoadhesion, permeation and pharmacokinetics study
Ghulam Mustafa, Akhtar Rasul, Ghulam Abbas, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access
Galanin N-terminal fragment (1−15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system
Noelia Cantero-García, Antonio Flores‐Burgess, Juan Pedro Pineda-Gómez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113508-113508
Open Access | Times Cited: 2
Page 1

Scroll to top